Agile Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>AT</div>
AGRX -- USA Stock  

USD 2.96  0.09  3.14%

Agile Stock News module provides quick insight into current market opportunities from investing in Agile Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Agile Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Please continue to Agile Therapeutics Hype Analysis, Agile Therapeutics Correlation and Agile Therapeutics Performance.

Search Today's Stock News

 
Refresh
Agile Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Agile daily returns and investor perception about the current pice of Agile Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Exercise or conversion by Dennis Reilly of 37500 shares of Agile Therapeutics subject to Rule 16b-3
Filed transaction by Agile Therapeutics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Agile insider trading alert for exercise of employee stock option (right to buy) by Dennis Reilly, Chief Financial Officer, on 26th of August 2020. This event was filed by Agile Therapeutics Inc with SEC on 2020-08-26. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   

Cash and Equivalents

Cash and Equivalents Comparative Analysis

Agile Therapeutics is currently under evaluation in cash and equivalents category among related companies. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Peers

Agile Therapeutics Related Equities

ACBAurora Cannabis   6.79   
0%
100.0%
EGRXEagle Pharmaceuticals   2.55   
0%
37.0%
ELANElanco Animal Health   2.40   
0%
35.0%
BHCBausch Health Companies   0.54   
0%
7.0%
FLXNFlexion Therapeutics   0.08   
0%
1.0%
DRRXDURECT   1.12   
16.0%
0%
EVOKEvoke Pharma   2.21   
32.0%
0%
EOLSEvolus Inc Common   5.50   
81.0%
0%
ENDPEndo International Plc   6.52   
96.0%
0%
Please continue to Agile Therapeutics Hype Analysis, Agile Therapeutics Correlation and Agile Therapeutics Performance. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.